ambroxol has been researched along with Asphyxia Neonatorum in 1 studies
Ambroxol: A metabolite of BROMHEXINE that stimulates mucociliary action and clears the air passages in the respiratory tract. It is usually administered as the hydrochloride.
Asphyxia Neonatorum: Respiratory failure in the newborn. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Renzo, GC | 1 |
| Anceschi, MM | 1 |
| Guidetti, R | 1 |
| Cosmi, EV | 1 |
1 trial available for ambroxol and Asphyxia Neonatorum
| Article | Year |
|---|---|
Requirements of perinatal prevention and treatment of respiratory distress syndrome.
Topics: Ambroxol; Aminophylline; Asphyxia Neonatorum; Clinical Trials as Topic; Double-Blind Method; Female; | 1989 |